Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

Main Results of 2025 Annual and Extraordinary General Meeting

The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, Grand Duchy of Luxembourg. All of the draft resolutions on the 2025 AGM agenda were approved. Notarized meeting minutes and voting results will be published on the Company’s special web portal for the 2025 Annual General Meeting at: ...

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at…

In order to participate, please register in advancehereto obtain a local or toll-free phone number and your personal pin.A live webcast of the call will be available on Teva's website at:https://ir.tevapharm.com/Events-and-Presentations.Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website. About TevaTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one...

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY…

Saint-Herblain (France), June 25, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General Meeting held today in Lyon, France. Among the adopted resolutions were the approval of the 2024 financial statements, delegations for the Board of Directors to increase Valneva’s share capital and/or issue financial instruments, the...

Liver Disease Treatments: Global Market Forecast and Emerging Trends Through…

This report provides a comprehensive analysis of the global market for liver disease treatment. It covers various liver conditions like hepatitis, non-alcoholic fatty liver disease (NAFLD) and liver cancer, along with their treatment options. It evaluates the impact of key products, clinical trials, new technologies, and recent drug approvals. The report also analyzes market trends across five major regions—North America, Europe, Asia-Pacific, South America, and the Middle East and…

Insulin Delivery Device Market worth $52.7 billion by 2030 with 8.3% CAGR |…

Browse in-depth TOC on 'Insulin Delivery Device Market' Browse in-depth TOC on 'Insulin Delivery Device Market' 500 - Tables 60 - Figures 350 - Pages By Based on type,the insulin delivery devices market is categorized by type into insulin pens, insulin pumps, insulin pen needles, insulin syringes, and other insulin delivery devices. The insulin pumps segment is anticipated to experience the fastest growth during the forecast period. This growth can be attributed to increasing...

Disclosure of share transfer from Inven2 AS

Issuer:Zelluna ASAISIN:NO0013524942Date of transaction:25 June 2025Inven2 AS, a major shareholder in Zelluna ASA, has transferred a total of 120,796 shares in Zelluna ASA to two inventors, in accordance with a pre-existing private agreement.Following the transaction, Inven2 AS holds 2,207,033 shares in Zelluna ASA, corresponding to 10.79% of the company’s outstanding shares.Non-Regulatory Press Release

Novartis completes acquisition of Regulus Therapeutics

Basel, June 25, 2025– Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of common stock, par value $0.001 per share (the “Shares”), of Regulus, have ceased trading on the Nasdaq Stock Market LLC and Regulus is now an indirect wholly owned subsidiary of Novartis.“We are pleased to complete this transaction and take the next step in advancing clinical development for a...

96% of health care executives are "ready and resourced" to use digital health…

"Rapid advancements in digital technologies offer exciting opportunities to improve the delivery of health care," says Corinne Dive-Reclus, head of digital diagnostics at Roche Diagnostics. "Connecting diagnostic systems and instruments in secure, compliant ways can help deliver new insights to improve operational and clinical decision-making. We work daily with health care leaders globally to use these new digital technologies that help improve delivery of patient care."…

Evaxion expands R&D pipeline with new vaccine program targeting Group A…

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combatGroup AStreptococcus(GAS)New vaccine program is added to Evaxion’s pipeline under the name EVX-B4Urgent need for preventive measures against GAS underscores the significant medical and commercial potential of EVX-B4Addition of a novel infectious disease candidate to the pipeline is in line with Evaxion’s partnership strategyCOPENHAGEN,...

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing…

As global leader in the development and manufacturing of OTF LTS continues to strengthen its position as a platform specialist by leveraging deep expertise to deliver exceptional outcomes for partners and their patients. Committed to innovation and long-term growth, LTS is actively investing in the future through collaboration with other organizations, advanced R&D resources, and expanded manufacturing capacity. These efforts ensure LTS remains at the forefront of oral thin film technology…

Biogen to Advance Investigational Spinal Muscular Atrophy Asset to…

Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in spinal muscular atrophy (SMA)Interim Phase 1 data show children with SMA previously treated with gene therapy experienced a substantial slowing of neurodegeneration and clinically meaningful improvements in motor function following initiation of salanersenBased on these encouraging Phase 1 data, Biogen is engaging with regulators to advance...

Sunseeker Robotics Debuts Its First LiDAR-Equipped Robotic Mower at Spoga+Gafa…

Product Innovation Across All Series Product Innovation Across All Series Located atHall 6.1 E037, Sunseeker has showcased its all-new L-Series, S-Series, and existing V-Series robots—each designed to address specific lawn sizes, terrain types, and budget considerations. Before Spoga+Gafa, Sunseeker also exhibited atDemopark 2025, where it introduced its high-endX-Seriesproducts to European high-end consumers and professionals. Among the highlights of the exhibition is the...

Slide Stainers Market to Reach $5.53 Billion by 2032, Growing at a CAGR of 7.9%…

The substantial growth of the slide stainers market is driven by the rapidly aging global population coupled with the escalating burden of chronic diseases requiring precise diagnostic capabilities. The market's expansion is fueled by technological advancements in automated slide staining systems, increasing demand for personalized treatments, rising healthcare expenditure, and the critical need for automation in diagnostics and clinical research across leading healthcare institutions worldwide.

Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal…

Professor Ali Tavassoli, Co-Founder and Chief Scientific Officer at Curve Therapeutics, said: "I am deeply honored to receive this award. However, scientific progress is never a solo endeavor, and I'm incredibly fortunate to work with an exceptional team, whose dedication, creativity and collaboration have been central to advancing our shared vision for intracellular screening of cyclic peptide libraries. Today's award therefore reflects the collective efforts of many people. I would like…

Medical Ceramics Market to Reach $29.93 Billion by 2032, Growing at a CAGR of…

The robust growth of the medical ceramics market is driven by the growing utilization of active implantable devices, rising adoption of ceramics in innovative drug delivery systems, high acceptance of ceramics in dental and orthopedic implants, and increasing demand for bio-ceramics in cosmetic dentistry. The market's expansion is further fueled by the rising demand for custom-engineered medical implants and breakthrough applications in cancer treatment and diagnostics. The robust growth of…

Tooth Replacement Market to Reach $30.6 Billion by 2032, Growing at a CAGR of…

The robust growth of the tooth replacement market is driven by the alarming prevalence of dental disorders, particularly dental caries and edentulism, affecting billions globally. The market's expansion is fueled by rising demand for cosmetic dental procedures, revolutionary adoption of digital technologies including CAD/CAM systems and 3D printing and increasing awareness of oral health importance across key global markets. The robust growth of the tooth replacement market is driven by the...

Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses

Raphael Ortiz, Chief Executive Officer, Telix International, commented, "We are excited to launch Telix's commercial radiopharmacy capability in Europe and demonstrate our ability to meet the needs of patients and partners. Through our bench-to-bedside capabilities we can now provide GMP-grade products and radiolabelling services to customers in Europe and beyond. This is a further point of differentiation for Telix." Raphael Ortiz, Chief Executive Officer, Telix International…

Dräger: New research should serve as a 'wake up call' for businesses to avoid…

It is hoped that the findings may serve as a wake-up call for those businesses that may not be fully aware of the extent of employee sentiment towards the issues involved. It is hoped that the findings may serve as a wake-up call for those businesses that may not be fully aware of the extent of employee sentiment towards the issues involved. Matthew Bedford, Managing Director, Draeger Safety UK Ltd comments: "The outlook for businesses continues to be extremely challenging, not least...

Positive Top Line Results from Confirmatory Efficacy Study for Proposed…

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025)— Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare...

£7.5 million Longitude Prize on ALS launches

Although some very limited treatments exist to slow the progression of ALS for a short time, its complexity means there are no long-term treatments and no cure. For the first time, however, AI advances mean innovators have the opportunity to outpace the disease. Although some very limited treatments exist to slow the progression of ALS for a short time, its complexity means there are no long-term treatments and no cure. For the first time, however, AI advances mean innovators have the...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu)…

The abstract can be found here: https://www.xcdsystem.com/snmmi/program/B95p18u/index.cfm?pgid=2402&sid=46736&abid=146032 The abstract can be found here:https://www.xcdsystem.com/snmmi/program/B95p18u/index.cfm?pgid=2402&sid=46736&abid=146032 The data presented analysed tumour, kidney, salivary gland, and other healthy organ-absorbed radiation doses, and calculated tumour-to-kidney (T:K) and tumour-to salivary gland (T:S) ratios. These data used a tumour dosimetry methodology…

Main Results of 2025 Annual and Extraordinary General Meeting

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at…

DBV Technologies Announces First Subject Screened in COMFORT Toddlers…

Bondholders approve amended terms of the 2025 and 2028 convertible bonds

Oxurion Receives Transparency Notification from Atlas Special Opportunities II…

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY…

Liver Disease Treatments: Global Market Forecast and Emerging Trends Through…

Insulin Delivery Device Market worth $52.7 billion by 2030 with 8.3% CAGR |…

Disclosure of share transfer from Inven2 AS

Novartis completes acquisition of Regulus Therapeutics

96% of health care executives are "ready and resourced" to use digital health…

Evaxion expands R&D pipeline with new vaccine program targeting Group A…

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing…

Biogen to Advance Investigational Spinal Muscular Atrophy Asset to…

Sunseeker Robotics Debuts Its First LiDAR-Equipped Robotic Mower at Spoga+Gafa…

Slide Stainers Market to Reach $5.53 Billion by 2032, Growing at a CAGR of 7.9%…

Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal…

Medical Ceramics Market to Reach $29.93 Billion by 2032, Growing at a CAGR of…

Tooth Replacement Market to Reach $30.6 Billion by 2032, Growing at a CAGR of…

Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses

Dräger: New research should serve as a 'wake up call' for businesses to avoid…

Positive Top Line Results from Confirmatory Efficacy Study for Proposed…

£7.5 million Longitude Prize on ALS launches

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu)…